Projects

Subprojects of the second funding period 2022-2025

Completed projects

  • TP07E Defining the role of hepatocellular carcinoma-related epigenetic alterations driving immune evasion, Susanne Strand (I. Medical Center und Polyclinic, University Medical Center in Mainz) & Jens Marquardt (I. Medical Center, UKSH – Campus Lübeck)
  • TP14E Immunomodulation of cytomegalovirus latency and reactivation by regulatory T cells and dendritic cells, Rafaela Holtappels (Institute for Virology) & Björn Clausen (Institute for Molecular Medicine) both at the University Medical Center Mainz
  • Z01E Integrated OMICS and Bioinformatics Platform, Stefan Tenzer (Institute for Immunology, University Medical Center Mainz) & Valesca Bukur (TRON - Translational Onkology gGmbH)

Subprojects of the first funding period 2018-2021

  • TP01 (Bopp/Schmitt): ICER-steered transcriptional regulation in macrophage-driven immune evasion mechanisms of malignant melanoma
  • TP02 (Beling/Ruf): TF-PAR2 signaling in TLR3-induced lung inflammation and Coxsackievirus infection
  • TP04 (König): SAMHD1: Impact on inflammation and DNA damage response in HIV-1 and malignant diseases
  • TP05 (Rajalingam): Oncogenic MAPK signaling in regulating anti tumor immunity
  • TP06 (Munder/Theobald): Molecular T cell immunotherapy and inhibition of tumor immune escape mechanisms
  • TP07 (Strand/Marquardt): Defining the role of hepatocellular carcinoma-related epigenetic alterations driving immune evasion
  • TP08 (Sprinzl/Schuppan): Characterization and modulation of innate myeloid cells in hepatocellular carcinoma
  • TP09 (Schmidt/Zipp): Mechanisms of immune evasion by malignant glioma
  • TP10 (Graf/Ruf): Immune modulation by the endothelial protein C receptor (EPCR) in cancer progression
  • TP11 (Lemmermann/Reddehase): Viral evasion of innate and adaptive immune cells and ‘inbetweeners’
  • TP12 (Fulda/Ullrich): Overcoming inefficient tumor immunity by Smac mimetics
  • TP13 (Probst/Schild): Suppressive mechanisms of regulatory T cells controlling CD8+ T cells in steady state, cancer and chronic infection
  • TP14 (Holtappels/Clausen): Immunomodulation of cytomegalovirus latency and reactivation by regulatory T cells and dendritic cells
  • TP15 (von Stebut-Borschitz/Waisman): Mechanisms controlling Th17 and regulatory T cells in the anti-Leishmania response
  • TP16 (Greten): Functional analysis of IL-17RA signaling in colorectal carcinogenesis
  • TP17 (Kreiter/Sahin): Neo-epitope specific CD4+ T cells – Anti-tumoral mechanisms and their modulation
  • TP18 (Sparwasser): Inhibition of tumor-associated Regulatory T cells by microbial metabolites
  • Z01 (Tenzer/Bukur): Integrated OMICS and Bioinformatics Platform
  • IRTG (Bopp/Clausen): Integrated Research Training Group